Detecting medication errors in pharmacovigilance database: Capacities and limits

International Journal of Risk and Safety in Medicine

Volumn 19, Issue 4, 2007, Pages 187-194

  Alj, L ^a   Touzani, M D W ^b   Benkirane, R ^a   Edwards, I R ^c   Soulaymani, R ^a  

^a Moroccan Pharmacovigilance Centre   (Morocco)

^b MOHAMMED V UNIVERSITY   (Morocco)

^c UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

Database; Detection; Medication errors; Patient safety; Pharmacovigilance; Preventability

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; BROMAZEPAM; DICLOFENAC; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CYTOLYSIS; DATA BASE; DRUG SURVEILLANCE PROGRAM; EXTRAPYRAMIDAL SYNDROME; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HEPATITIS; HUMAN; MACULOPAPULAR RASH; MALE; MEDICATION ERROR; MOROCCO; NEWBORN; PATIENT SAFETY; PERIPHERAL NEUROPATHY; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; TOXIC EPIDERMAL NECROLYSIS; UNSPECIFIED SIDE EFFECT;

EID: 36549079551     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. D.W. Bates, D.L. Boyle, M.B. Vander Vliet, J. Schneider and L. Leape, Relationship between medication errors and adverse drug events, J. Gen. Intern. Med. 10 (1995), 199-205.
2. B. Bégaud, J.C. Evreux, J. Jouglard et al., Imputabilité des effets inattendus ou toxiques des médicaments, Thérapie 40 (1985), 111-118.
3. R. Benkirane, R. Soulaymani et al., Prevalence and preventability of adverse drug events in a teaching hospital: cross sectional study, Manuscript (No: 06/581) under publication in: The Eastern Mediterranean Health Journal.
4. P. Caduff-Janosa, Medication errors in Switzerland: an analysis of the spontaneous adverse reaction reports received at the Swissmedic Pharmacovigilance Centre, Drug Saf. 27 (2004), 831-977.
5. Guidelines for ATC classification and DDD assignment, WHO Collaborating Centre for Drugs Statistics Methodology, Oslo 2002. Available at website http://www.whocc.no.
6. P. Kanjanarat, A.G. Winterstein, T.E. Johns, R.C. Hatton, R. Gonzalez-Rothi and R. Segal, Nature of preventable adverse drug events in hospitals: a literature review, Am. J. Health-Syst. Ph. 60 (2003), 1750-1759.
7. L.T. Kohn, J.M. Corrigan and M.S. Donaldson (eds), To Err is Human: Building a Safer Health System, National Academy Press, Washington, DC, 2000.
8. B.J. Kopp, B.L. Erstad, M.E. Allen et al., Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection, Crit. Care Med. 34 (2006), 415-425.
9. Massachusetts Medical Society (MMS Headquarters), 860 winter street Waltham Woods corporate Centre Waltham, ma 02451-1411. Available at http://www.massmed.org/Content/NavigationMenu/About/DirectionstoMMS/ Directions_to_MMS_Headquarters.htm - 83k -.
10. P.J. McDonnell and M.R. Jacobs, Hospital admissions resulting from preventable adverse drug reactions, Ann. Pharmacother. 36 (2002), 1331-1336.
11. National Coordinating Council for Medication Errors Reporting and Prevention NCC, MERP Taxonomy of Medication Errors, Pharm. Hosp. 37 (2002), 203-204. Site internet http://www.nccmerp.org.
12. P. Olivier, J. Caron, F. Haramburu, J.L. Imbs, A.P. Jonville-Béra, G. Lagier et al., Validation d'une échelle de mesure: exemple de l'échelle française d'évitabilité des effets indésirables médicamenteux, Thérapie 60 (2005), 39-45.
13. M. Pirmohamed, J. Sally, M. Shaun et al., Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients, BMJ 329 (2004), 15-19.
14. P. Pouyanne, F. Haramburu, J.L. Imbs et al., Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French pharmacovigilance Centres, BMJ 320 (7241) (2000), 1036.
15. E.J. Thomas and T.A. Brennan, Incidence and types of preventable adverse events in elderly patients: population based review of medical records, BMJ 320 (2000), 741-744.
16. P. Tudoux, Evaluation de l'évitabilité des effets indésirables médicamenteux: étude rétrospective au sein du CHU d'Angers, Thèse pour l'obtention du Doctorat en Médecine, 13 Décembre, 2004.
17. World Health Organization collaborating centre for International Drug Monitoring (UMC), Safety monitoring of medicinal products: Guidelines for setting up and running a Pharmacovigilance Centre, Equus, London, 2000. Available at http:www.who-umc.org.
18. World Health Organization collaborating centre for International Drug Monitoring (UMC), The importance of pharmacovigilance, safety monitoring of medicinal products, Equus, London, 2000. Available at http:www.who-umc.org.
19. World Health Organization collaborating centre for International Drug Monitoring (UMC), WHO Adverse Reaction Terminology, December 2002. Available at http://umc-products.com/graphics/3149.pdf.